09:05 AM EST, 12/27/2024 (MT Newswires) -- Health care stocks were mixed pre-bell Friday as the iShares Biotechnology ETF (IBB) was 0.1% higher and the Health Care Select Sector SPDR Fund (XLV) was down 0.2% recently.

UnitedHealth Group (UNH) and Amedisys (AMED) extended the deadline for closing their $3.3 billion merger agreement as the US Department of Justice scrutinizes the deal, a filing showed. Amedisys shares rose past 4% premarket.

Takeda Pharmaceutical (TAK) shares were up over 1% after the company said the Japanese Ministry of Health, Labor and Welfare has approved the use of Hyqvia in patients with agammaglobulinemia or hypogammaglobulinemia.

Exicure (XCUR) shares advanced by about 9% after the company said it signed a memorandum of understanding with GPCR Therapeutics for the acquisition of the South Korean company's US subsidiary, GPCR USA, to advance its growth as a clinical-stage biotech firm.

http://www.mtnewswires.com
Copyright © 2024 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.